SHPH Shuttle Pharmaceuticals Hol...

Nasdaq shuttlepharma.com


$ 2.10 $ 0.19 (9.9 %)    

Tuesday, 18-Nov-2025 15:57:37 EST
QQQ $ 597.12 $ -7.35 (-1.22 %)
DIA $ 461.67 $ -5.02 (-1.08 %)
SPY $ 660.81 $ -5.59 (-0.84 %)
TLT $ 89.05 $ -0.03 (-0.03 %)
GLD $ 374.31 $ 2.70 (0.73 %)
$ 2.11
$ 1.90
$ 2.07 x 100
$ 2.10 x 40
$ 1.99 - $ 2.11
$ 1.85 - $ 25.25
65,442
na
3.38M
$ 5.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-Q
3 05-08-2025 03-31-2025 10-Q
4 02-26-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 09-04-2024 06-30-2024 10-Q
7 05-13-2024 03-31-2024 10-Q
8 03-21-2024 12-31-2023 10-K
9 11-13-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-25-2023 03-31-2023 10-Q
12 03-15-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 shuttle-pharmaceuticals-q3-eps-105-up-from-3975-yoy

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(1.05) per share. This is a 97.36 percent increase over los...

 shuttle-pharma-executes-non-binding-loi-to-acquire-moleculeai-and-its-platform-for-10m-in-combination-of-cash-and-common-shares

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

 shuttle-pharmaceuticals-announces-non-binding-loi-to-purchase-moleculeai-for-10m

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

 shuttle-pharmaceuticals-q2-eps-329-up-from-2412-yoy

Shuttle Pharmaceuticals (NASDAQ:SHPH) reported quarterly losses of $(3.29) per share. This is a 86.36 percent increase over los...

 shuttle-pharmaceuticals-has-been-granted-us-patent-number-12357650-titled-methods-and-compositions-for-cancer-therapies-that-include-delivery-of-halogenated-thymidines-and-thymidine-phosphorlylase-inhibitors-in-combination-with-radiation

https://ppubs.uspto.gov/pubwebapp/external.html?q=(12357650).pn

 shuttle-pharmaceuticals-announces-pricing-of-425m-private-placement-at-a-purchase-price-of-360-per-share

Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) ("Shuttle Pharma" or the "Company"), a discovery and devel...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION